Optimization of a standard protocol for linear amplification of tumor RNA extracted from Fine Needle Aspirates (FNA) of pancreatic tumors.

Optimization of a standard protocol for linear amplification of tumor RNA extracted from Fine Needle Aspirates (FNA) of pancreatic tumors. - Optimization of a tumor RNA- amplificationprotocol

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34795

Enrollment

Registered

2010-09-17

Start date

2010-09-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic adenocarcinoma pancreatic cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: inoperable pancreatic adenocarcinoma

Exclusion criteria

Exclusion criteria: operable PC

Design outcomes

Primary

Measure	Time frame
Determination of the amplified RNA quality by performing a qualitative assay before and after amplification using Taqman probes.	—

Countries

Netherlands

Outcome results